Your email has been successfully added to our mailing list.

×
-0.000936484327659271 0.000275436566958692 0.00225857984906074 0.00754696193466647 0.00435189775794646 0.0103013276042528 0.00842835894893407 0.00842835894893407
Stock impact report

Is Acceleron Pharma Stock a Buy? [The Motley Fool]

Acceleron Pharma Inc. (XLRN) 
Last acceleron pharma inc. earnings: 2/27 04:05 pm Check Earnings Report
Company Research Source: The Motley Fool
Last week, Acceleron Pharma ( NASDAQ:XLRN stock to skyrocket Image source: Getty Images. What happened? Acceleron reported that its drug sotatercept successfully met the primary and secondary endpoints in a phase clinical trial A little history To understand Acceleron, an investor needs to look back into its history, particularly its longstanding relationship with Celgene, now part of Bristol-Myers Squibb The companies subsequently amended the agreement in 0 and again in 07, the latest version giving Acceleron the rights to sotatercept for pulmonary hypertension, including PAH, while Celgene maintained rights to all other disease indications. Over the years, Celgene paid $. million in R&D expenses related to the program. Initially, the companies sought to develop the drug for cancer-related bone loss. Celgene expanded its relationship with Acceleron by acquiring the rights to a second drug called luspatercept. This drug rapidly took center stage for Celgene. The company quickly advan Show less Read more
Impact Snapshot
Event Time:
XLRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for XLRN alerts
Opt-in for
XLRN alerts

from News Quantified
Opt-in for
XLRN alerts

from News Quantified